Back Policy/Litigation
Back Resolutions
Back Current Initiatives
Back Donate
Home » In The News » In rebuke to pharma, one-fifth of Bristol-Myers shareholders favor proposal tying pricing risks to executive pay

In rebuke to pharma, one-fifth of Bristol-Myers shareholders favor proposal tying pricing risks to executive pay

Stat News